FDA Drug Label
ELMIRON (pentosan polysulfate sodium) — Prescribing Information
Janssen Pharmaceuticals. FDA Drug Label. 1996
Compare
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Last reviewed . By the PeptIQ team.
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 0% · Mixed 17% · Unfavorable overall 83%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0–25 mcg · Most common: 0–25 mcg
Reports cluster around 0–25 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 3% · Mixed 97% · Unfavorable overall 0%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg
Reports span 0.1 to ≥ 5 mg (open-ended top bucket)
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 86% said they felt similar to their last entry, 14% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 54 days · Based on 35 repeat reporters
Published sources linked on the Pentosan Polysulfate and Selank wiki pages.
FDA Drug Label
Janssen Pharmaceuticals. FDA Drug Label. 1996
PubMed
Bannuru RR, Osani MC, Vaysbrot EE, et al. Osteoarthritis Cartilage. 2020
PubMed
Siddiq MAB, Oo WM, Hunter DJ. Joint bone spine. 2024
PubMed
Ghosh P. Seminars in arthritis and rheumatism. 1999
PubMed
Ershov FI, Uchakin PN, Ershova OV. Bull Exp Biol Med. 2017
PubMed
Seredenin SB, Kozlovskaya MM. Bull Exp Biol Med. 2008
PubMed
Ershov FI, Uchakin PN. Bull Exp Biol Med. 2010
ClinicalTrials.gov
ClinicalTrials.gov. Clinical trial registry. 2024
PubMed
Panikratova YR, Lebedeva IS, Sokolov OY, et al. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections. 2020
PubMed
Konstantinopolsky MA, Chernyakova IV, Kolik LG. Bulletin of experimental biology and medicine. 2022